GSK Vaccines , Wavre, Belgium.
Hum Vaccin Immunother. 2020 Nov 1;16(11):2861-2872. doi: 10.1080/21645515.2020.1739485. Epub 2020 Apr 16.
This study is aimed to review the published evidence on safety, immunogenicity, and efficacy of rotavirus vaccines when co-administered with meningococcal vaccines in infants. A systematic literature search was performed in four databases containing peer-reviewed articles and conference abstracts. In total, twelve articles were included in the review; 11 provided information on safety and five on the immunogenicity of rotavirus vaccines following co-administration. No paper was found on efficacy. Additional routine vaccines were administered in all studies. The safety analysis was mainly focused on fever, vomiting, diarrhea, intussusception, and changes in eating habits. Overall, safety profiles and immune responses associated with rotavirus vaccination were comparable between infants co-administered with rotavirus and meningococcal vaccines and infants receiving rotavirus vaccines without meningococcal vaccines. Although data are limited, co-administration of rotavirus and meningococcal vaccines does not appear to interfere with the safety or immunogenicity of rotavirus vaccines.
本研究旨在综述轮状病毒疫苗与脑膜炎球菌疫苗联合用于婴儿时的安全性、免疫原性和有效性的已发表证据。在四个包含同行评审文章和会议摘要的数据库中进行了系统的文献检索。共有 12 篇文章纳入综述;11 篇提供了联合使用后轮状病毒疫苗安全性方面的信息,5 篇提供了轮状病毒疫苗免疫原性方面的信息。没有发现关于有效性的论文。所有研究均额外接种了常规疫苗。安全性分析主要集中在发热、呕吐、腹泻、肠套叠和饮食习惯改变上。总体而言,联合使用轮状病毒和脑膜炎球菌疫苗的婴儿与单独使用轮状病毒疫苗的婴儿的安全性概况和免疫反应相当。尽管数据有限,但轮状病毒和脑膜炎球菌疫苗联合使用似乎不会干扰轮状病毒疫苗的安全性或免疫原性。